Only a few new yellow fever cases have been reported in Angola in the past week, but the mostly urban epidemic is still a big concern because of persistent transmission in seven provinces and expansion to new ones, the World Health Organization (WHO) said in its weekly update today.
As part of the effort to preserve medically important antimicrobials, pharmaceutical companies will henceforward be required to report sales of antimicrobial drugs for food animals by species, not just overall totals, the US Food and Drug Administration (FDA) announced yesterday.
Takeda Pharmaceutical Company today announced a $38 million grant from the Bill and Melinda Gates Foundation, part of a partnership to develop a safe, effective, and affordable Sabin-strain inactivated polio vaccine (IPV) for developing countries.
Two Ebola case-patients, both children, and one fatality in Liberia have been linked to a fatal Ebola infection in Guinea's ongoing flare-up, the World Health Organization (WHO) announced today, increasing the number of recent cases in Liberia to three.
Saudi Arabia's Ministry of Health (MOH) today reported a new, fatal MERS-CoV case in Buraydah, the first there this month after the city reported 34 MERS cases in March.
Members of the JIKI Study Group reported inconclusive and varied results for use of the antiviral medication favipiravir to treat Ebola virus disease, according to a study yesterday in PLOS Medicine.
Saudi Arabia's Ministry of Health (MOH) today confirmed two new MERS-CoV infections in Saudi men, marking 11 new cases in as many days.
The move signals the end of enhanced screening in the United States related to West Africa's Ebola outbreak.
The US Centers for Disease Control and Prevention (CDC) saw localized pockets of high flu activity last week, but for the nation as a whole, the levels rose only slightly again, according to today's weekly update.
The percentage of respiratory specimens that tested positive for flu registered a modest bump, increasing from 6.8% to 9.1% last week, with the 2009 H1N1 virus holding onto its spot as the predominant strain.
A pair of US biotechnology companies today announced the launch of what appears to be the first phase 1 clinical trial of a MERS-CoV vaccine, while the World Health Organization (WHO) provided more details on the MERS-CoV case reported in Thailand earlier this week.
